Keywords: China, SFDA, Technology transfer for medicines, Guangdong, Implications, EIU analyst

China's SFDA delegates technology transfer of medicines in Guangdong

Article | 16 November 2012

China’s pharma products regulatory authority the State Food and Drugs Administration has delegated power to approve technology transfer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in